May 6 |
Rhythm Pharmaceuticals Q1 2024 Earnings Preview
|
May 6 |
Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meeting
|
May 1 |
Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know
|
Apr 30 |
Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q1 Earnings Expected to Decline
|
Apr 29 |
Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology
|
Apr 24 |
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
|
Apr 16 |
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
|
Apr 14 |
Market Sentiment Around Loss-Making Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
|
Apr 10 |
Moderna (MRNA) Surges 6.2%: Is This an Indication of Further Gains?
|
Apr 7 |
Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst
|